Journal profile · Cardiac & Cardiovascular Systems
Heart Failure Reviews
ISSN 1382-4147 · eISSN 1573-7322 · Springer US · NETHERLANDS · Quarterly · Founded 1996
Heart Failure Reviews: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.31; hybrid open access; APC about USD 3,090; median 77 days to acceptance (57 articles, last 24 months); community-reported acceptance: moderate; 106 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Heart Failure Reviews is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors and Cardiac pacing and defibrillation studies, together about 38.9% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Heart Failure Reviews is an international journal which develops links between basic scientists and clinical investigators, creating a unique, interdisciplinary dialogue focused on heart failure, its pathogenesis and treatment. The journal accordingly publishes papers in both basic and clinical research fields. Topics covered include clinical and surgical approaches to therapy, basic pharmacology, biochemistry, molecular biology, pathology, and electrophysiology.The reviews are comprehensive, expanding the reader's knowledge base and awareness of current research and new findings in this rapidly growing field of cardiovascular medicine. All reviews are thoroughly peer-reviewed before publication.
From the journal's Aims & Scope
Research area (LetPub): Cardiac & Cardiovascular Systems
Editor-in-chief Andrew P. AmbrosyPublisher website
Editorial board by country: none in mainland China; most named United States 45, Italy 9, Japan 5, Greece 5, United Kingdom 3 (96 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Heart Failure Treatment and ManagementMedicine17.4%
- Cardiovascular Function and Risk FactorsMedicine14.8%
- Cardiac pacing and defibrillation studiesMedicine6.7%
- Cardiac Structural Anomalies and RepairMedicine5.7%
- Cardiac electrophysiology and arrhythmiasMedicine5.1%
- Cardiomyopathy and Myosin StudiesMedicine4.5%
- Mechanical Circulatory Support DevicesEngineering3.8%
- Cardiac Imaging and DiagnosticsMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.31LetPub ·
- Impact factor (publisher) 2025
- 5.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.3Publisher website ·
- CiteScore 2026-06
- 12.2LetPub ·
- SJR 2026-06
- 1.65LetPub ·
- SNIP 2026-06
- 1.83LetPub ·
- h-index
- 70LetPub ·
- h-index
- 123OpenAlex ·
- i10-index
- 1,354OpenAlex ·
- 2-year mean citedness
- 5.02OpenAlex ·
- Self-citation rate
- 1.9%LetPub ·
- Share of gold OA articles
- 36.92%LetPub ·
Volume
- Articles per year
- 102LetPub ·
- Downloads per year (publisher) 2025
- 914,600Publisher website ·
Articles by year OpenAlex count · 2,022 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 93 | 46 | 52 |
| 2025 | 106 | 57 | 566 |
| 2024 | 98 | 37 | 874 |
| 2023 | 89 | 39 | 1,614 |
| 2022 | 94 | 39 | 1,901 |
| 2021 | 141 | 54 | 4,200 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
77 daysMedian, submission to acceptance · P25–P75 54 days – 107 days
- Acceptance to online
- median 12 days (97 articles)
- Submission to online
- median 91 days
- Sample
- 57 articles with submission and acceptance dates (238 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,090 / EUR 4,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted12, with length limits
- commentaryState-of-the-Art Review [submit as Review] Review papers should provide a comprehensive and in-depth analysis of original research on a focused topic. Authors s…Length not stated
- consensus articleConsensus Article These may be solicited or unsolicited but should generally be prepared in collaboration with a national/international professional society and…Length not stated
- curriculum in heart failureCurriculum in Heart Failure [submit as Comment] Concise, cutting-edge, contemporary articles presenting core, updated information necessary for the continuing m…Length not stated
- debateDebate This is a commentary on a topic of ongoing uncertainty.Length not stated
- meeting reportMeeting Report We invite authors to submit brief synopsis from national, regional, and international conferences and scientific meetings.Length not stated
- mini reviewState-of-the-Art Review [submit as Review] Review papers should provide a comprehensive and in-depth analysis of original research on a focused topic. Authors s…main text ≤ 2,000 words · references ≤ 30
- original researchState-of-the-Art Review [submit as Review] Review papers should provide a comprehensive and in-depth analysis of original research on a focused topic. Authors s…Length not stated
- primerPrimer Concise clinical practice updated devoted to innovative new areas of development in cardiovascular diseases important to the frontline practicing cardiol…Length not stated
- research highlightResearch Highlight This article type will be used to provide updates on recently presented/published landmark studies and/or clinical trials.Length not stated
- reviewState-of-the-Art Review [submit as Review] Review papers should provide a comprehensive and in-depth analysis of original research on a focused topic. Authors s…Length not stated
- state-of-the-art reviewState-of-the-Art Review [submit as Review] Review papers should provide a comprehensive and in-depth analysis of original research on a focused topic.Length not stated
- study protocolStudy Protocol We encourage investigators to submit high-quality methods papers based on practice-changing observational studies, prospective cohort studies, an…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest AUTHOR DISCLOSURES
All authors must disclose all institutional or corporate/commercial relationships going back 36 months, or to the time of the data collection if the data were collected longer than 3 years ago, that might pose a conflict of interest. The Journal should also be informed if any conflicts of interest arise after submission and before publication of the paper. Institutional affiliations and funding so…
Source ↗Publisher website ·- Data availability Data availability statements
Data and code should support published claims and comply with field standards. Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Ethical standards
Ethics approval per Declaration of Helsinki required for human and animal studies. Model summary
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed conse…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
Open Choice articles keep copyright with authors under a Creative Commons license. Model summary
To find out more about publishing your work Open Access in Heart Failure Reviews, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Reviewers may be suggested or excluded by authors at submission. Model summary
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 1996
- ISSN
- 1382-4147
- Electronic ISSN
- 1573-7322
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Heart Failure Reviews
What CAS zone is Heart Failure Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Heart Failure Reviews is in Zone 2 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Heart Failure Reviews?
The latest impact factor listed by LetPub is 5.31; CiteScore 12.2, h-index 123.
How long does peer review take at Heart Failure Reviews?
Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 77 days (interquartile range 54–107 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Heart Failure Reviews?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Heart Failure Reviews based?
Of the 96 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (45), Italy (9) and Japan (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Heart Failure Reviews?
According to LetPub and DOAJ records, Heart Failure Reviews is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Heart Failure Reviews open access, and what is the APC?
Heart Failure Reviews is a hybrid journal. For open-access publication: APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .